Skip to content
Home/Companies/Healthcare/Sangro

Sangro

Healthcare·Germany·Active·New
Entry
2026
Hold
New
Status
Active

Who owns Sangro?

Sangro is currently owned by Axcel through Axcel VII (2023 vintage), since 2026.

Hand-verified · updated 2026-08-18

Axcel
Investor
Axcel
Axcel VII · 2023 · Buyout

Key facts

HQGermany
SectorHealthcare
StatusActive

More from Axcel VII

Other portfolio companies in the same fund.

Bekk
Active
IT ServicesNorway· 2026
Geomatikk Group
Geomatikk Group
Active
IT ServicesNorway· 2026
KapitalKontroll
Active
SoftwareNorway· 2026
Sanviva
Active
HealthcareDenmark· 2026
AGRD Partners
Active
Business ServicesSweden· 2025
LS Retail
Active
SoftwareIceland· 2025

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Acentra Health
Acentra Health
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Track Sangro

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Sangro?

6 strategic and 114financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Sangro.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue